StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) PT Lowered to $185 at Morgan Stanley Following EPS
February 23, 2023 12:39 PM
Morgan Stanley analyst Matthew Harrison lowered the price target on Moderna (NASDAQ: MRNA) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Moderna (MRNA) changes point to an 'extended period of underperformance' - SVB Securities
February 24, 2023 10:16 AM
Moderna (MRNA) PT Lowered to $214 at Piper Sandler
February 23, 2023 12:13 PM
Moderna falls as waning demand for COVID-19 vaccines hit sales, profit
February 23, 2023 9:06 AM
Moderna forecasts COVID sales decline as costs rise, shares fall
February 23, 2023 7:53 AM
Moderna (MRNA) Q4 Revenue Tops Consensus
February 23, 2023 7:05 AM
Form 8-K Moderna, Inc. For: Feb 23
February 23, 2023 7:03 AM
Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates
February 23, 2023 7:01 AM
